Bring on the CR if need be - the commercial runway for Celgro is going to be substantial. The soft tissue repair market is enormous and Orthocell's product offers these advantages over competitors:
- Completely acellular and therefore devoid of any reactive DNA
- Better tissue in-growth and repair by its defined structure
- Adequate mechanical properties according to tissue specificities
- Improved host tissue integration
- Australian sourced raw materials, which can be reproducibly manufactured in large commercial quantities, thus eliminating disease transmission concerns associated with foreign imports and human cadaveric donations.
Bring on the CR if need be - the commercial runway for Celgro is...
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
-0.005(1.27%) |
Mkt cap ! $81.63M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 39.5¢ | 38.5¢ | $29.16K | 75.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 75123 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 37896 | 2 |
View Market Depth
| Last trade - 14.32pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
39.0¢ |
Change
-0.005 ( 1.27 %) |
||||
| Open | High | Low | Volume | ||
| 38.5¢ | 39.0¢ | 38.5¢ | 25594 | ||
| Last updated 14.32pm 06/05/2024 ? | |||||
| OCC (ASX) Chart |